Ocugen to host webcast on phase 2 trial data for geographic atrophy therapy

March 23, 2026 7:02 AM

Ocugen Inc. (NASDAQ: OCGN) announced it will host a webcast on March 24 at 8 a.m. EDT to discuss Phase ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found